Cardiovascular (CV) Risk, Heart Attack Patients
Conditions
Keywords
secondary prevention, prevention, heart attack, lifestyle modification, cardiovascular disease
Brief summary
This study investigates health behaviour and readiness for lifestyle change in patients who recently had a heart attack (myocardical infarction) treated with stenting (PTCA). Despite successful acute treatment, many patients remain at increased risk of a second heart atttack because lifestyle changes are not consistently maintained. Participants who had a heart attack within the past 6 months will complete standardized questionnaires on readiness to change, quality of life, anxiety/depression, and physical functioning, plus a free-text section on personal barriers to change. Findings will characterize this population and inform a future lifestyle intervention trial
Detailed description
Cardiovascular diseses are the leading cause of deaths in Germany and worldwide. Even after successfull PTCA, reinfarction rates remain elevated, partly because patients often underestimate their ongoing risk, have limited knowledge of secondary prevention targets and show low self-efficacy for behavior change; anxiety and depression are also common after myocardial infarction. This single-center, cross-sectional study enrolls patients treated with PTCA within the past 6 months, recruited during their routine follow-up visit at the Lipidambulanz, Westdeutsches Herz- und Gefäßzentrum, University Hospital Essen. Participants complete validated questionnaires: PIAC (primary outcome; rediness to change), SF-36 (quality of life); HADS (anxiety/depression), and KCCQ-23 (physical functioning), plus sociodemographic data and free-text section on perceived barriers. This study is purely observational, involves no interventions or biospecimens and takes about 30 minutes. A sample of 143 participants was calculated for adequate precision in estimating the PIAC meand and supporting exploratory regression analyses, accounting for 10% dropout. Data collection runs 6 months, followed by 18 months of analysus. Results wull inform a planned randomized controlled trial.
Interventions
None listed
Sponsors
Kliniken Essen-Mitte
Universitätsklinikum Essen
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* age over 18 years * myocardial infarction within past 6 months * PTCA treatment
Exclusion criteria
* Age under 18 * history of multiple myocardial infactionrs * myocardial infarction more than 6 months prior * myocardial infarction not treated by PTCA * absence of informed consent * severe cognitive impairment precluding data collection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PIAC (Perception, Intention and Ability to Change) Scale | Single assessement at study enrollment, baseline | Readiness and ability to change health-related behavior, habits and living conditions, assessed using the PIAC questionnaire, a validated 9 item instrument covering awareness of negative health behaviors, intention to change and implementation of change strategies. Higher scores indicate a better awareness and intention to change. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| SF-36 (Short-form 36 Health Survey) | Single assessement at study enrollment, baseline | Health-related quality of life assessed using the SF-36, yielding a physical and a mental summary score; higher scores indicate better quality of life. |
| HADS (Hospital Anxiety and Depression Scale) | Single assessement at study enrollment, baseline | Anxiety and depressive Symptoms assessed using the HADS(-A) for Anxiety and HADS-(D) for depression. each ssubscales ranges from 0-21; higher scores indicate greater severity. |
| KCCQ-23 (Kansas City Cardiomyopathy Questionnaire) | Single assessement at study enrollment, baseline | Disease-specific health status using the KCCQ-23 covering physical limitations, symptoms, self-efficacy, social limitation and quality of life. Scores ranging 0-100 with higher scores indicating better health status. |
Countries
Germany
Contacts
CONTACTWiebke K Kohl-Heckl, Dr.med.
PRINCIPAL_INVESTIGATORWiebke Kohl, Dr.med
Center for Integrative Medicine and Planetary Health, University Hospital Essen
STUDY_DIRECTORGustav Dobos, Prof. Dr. med.
Center for Integrative Medicine and Planetary Health, University Hospital Essen
Outcome results
None listed